US Stock MarketDetailed Quotes

SBFM Sunshine Biopharma

Watchlist
  • 0.3929
  • +0.1077+37.76%
Close Jun 13 16:00 ET
  • 0.3847
  • -0.0082-2.09%
Post 19:59 ET
7.44MMarket Cap-29P/E (TTM)

Sunshine Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
54.09%7.54M
454.42%24.09M
94.94%7.68M
4,385.93%5.96M
3,599.67%5.56M
3,890.42%4.89M
1,802.41%4.35M
4,528.68%3.94M
163.63%132.81K
184.27%150.31K
Operating revenue
54.09%7.54M
454.42%24.09M
94.94%7.68M
4,385.93%5.96M
3,599.67%5.56M
3,890.42%4.89M
1,802.41%4.35M
4,528.68%3.94M
163.63%132.81K
184.27%150.31K
Cost of revenue
69.17%5.19M
494.69%15.75M
108.77%5.11M
5,931.06%3.97M
4,731.24%3.61M
5,023.12%3.07M
2,148.18%2.65M
3,895.36%2.45M
237.24%65.78K
303.36%74.68K
Gross profit
28.78%2.35M
391.53%8.34M
72.22%2.57M
2,869.42%1.99M
2,482.18%1.95M
2,811.02%1.83M
1,434.03%1.7M
6,157.61%1.49M
117.12%67.03K
120.10%75.62K
Operating expense
1.31%3.7M
26.55%13.12M
-42.47%3.76M
55.17%2.77M
281.42%2.94M
184.34%3.66M
306.57%10.37M
2,051.20%6.53M
238.63%1.79M
82.39%771.42K
Selling and administrative expenses
7.63%3.36M
14.26%10.83M
-56.02%2.82M
71.76%2.44M
237.71%2.44M
239.24%3.13M
408.01%9.48M
2,966.82%6.41M
371.58%1.42M
217.18%723.19K
-Selling and marketing expense
54.83%198.05K
27.01%734.25K
30.14%231.26K
11.13%241.9K
51.89%133.18K
34.59%127.91K
--578.09K
--177.7K
--217.67K
--87.68K
-General and administrative expense
5.62%3.17M
13.43%10.1M
-58.48%2.59M
82.72%2.2M
263.35%2.31M
262.78%3M
377.03%8.9M
2,881.83%6.23M
299.38%1.2M
178.73%635.51K
Research and development costs
-48.71%222.03K
128.59%1.86M
1,854.67%816.33K
-34.34%238.01K
702.22%368.57K
19.71%432.93K
20.77%811.86K
-54.21%41.76K
62.95%362.5K
-76.04%45.94K
Depreciation amortization depletion
22.78%42.62K
492.72%149.15K
123.16%42.35K
4,616.10%37.21K
1,425.01%34.88K
1,016.08%34.71K
97.50%25.16K
496.01%18.98K
-75.21%789
-28.35%2.29K
-Depreciation and amortization
22.78%42.62K
492.72%149.15K
123.16%42.35K
4,616.10%37.21K
1,425.01%34.88K
1,016.08%34.71K
97.50%25.16K
496.01%18.98K
-75.21%789
-28.35%2.29K
Other taxes
19.12%75.9K
424.57%289.74K
39.02%76.78K
--52.59K
--96.65K
--63.72K
--55.23K
--55.23K
--0
--0
Operating profit
26.16%-1.35M
44.83%-4.79M
76.43%-1.19M
54.63%-779.47K
-42.23%-989.62K
-49.50%-1.83M
-255.47%-8.67M
-1,701.26%-5.04M
-246.19%-1.72M
-79.05%-695.8K
Net non-operating interest income expense
-45.08%94.91K
40.78%674.67K
85.04%157.5K
-35.27%168.9K
20.14%175.45K
1,443.64%172.81K
245.75%479.24K
332.38%85.12K
656.97%260.94K
174.65%146.04K
Non-operating interest income
-32.63%144.09K
56.56%811.97K
68.01%187.61K
-20.51%207.43K
39.03%203.05K
7,129,266.67%213.88K
--518.65K
--111.67K
--260.94K
7,302,050.00%146.04K
Non-operating interest expense
19.73%49.18K
248.39%137.31K
13.43%30.11K
1,926,250.00%38.53K
--27.6K
219.30%41.08K
-88.01%39.41K
-27.53%26.55K
-100.00%2
--0
Other net income (expense)
-38,546.67%-5.77K
100.00%-245
100.00%-39
60.00%40
-102.40%-261
266.67%15
-89.46%-18.32M
-1,963.70%-18.33M
100.00%25
100.47%10.88K
Gain on sale of security
-38,546.67%-5.77K
48.53%-245
92.51%-39
60.00%40
-1,000.00%-261
266.67%15
-1,052.00%-476
-2,842.11%-521
-32.43%25
262.50%29
Special income (charges)
----
--0
--0
--0
--0
----
-89.46%-18.32M
-1,963.69%-18.33M
--0
100.47%10.85K
-Less:Impairment of capital assets
----
--0
----
----
----
----
--18.33M
----
----
----
-Less:Other special charges
----
----
----
----
----
----
-100.11%-10.85K
--0
----
-100.47%-10.85K
Income before tax
23.83%-1.26M
84.49%-4.11M
95.58%-1.03M
58.10%-610.53K
-51.14%-814.43K
-33.97%-1.66M
-113.17%-26.51M
-3,589.50%-23.28M
63.93%-1.46M
81.28%-538.87K
Income tax
-51.69%22.35K
69.38%395.17K
-5.59%220.27K
40.95K
87.68K
46.27K
233.3K
233.3K
0
0
Net income
24.59%-1.28M
83.15%-4.51M
94.68%-1.25M
55.29%-651.48K
-67.41%-902.11K
-37.71%-1.7M
-115.05%-26.74M
-3,624.47%-23.51M
63.93%-1.46M
81.28%-538.87K
Net income continuous Operations
24.59%-1.28M
83.15%-4.51M
94.68%-1.25M
55.29%-651.48K
-67.41%-902.11K
-37.71%-1.7M
-115.05%-26.74M
-3,624.47%-23.51M
63.93%-1.46M
81.28%-538.87K
Minority interest income
Net income attributable to the parent company
24.59%-1.28M
83.15%-4.51M
94.68%-1.25M
55.29%-651.48K
-67.41%-902.11K
-37.71%-1.7M
-115.05%-26.74M
-3,624.47%-23.51M
63.93%-1.46M
81.28%-538.87K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
24.59%-1.28M
83.15%-4.51M
94.68%-1.25M
55.29%-651.48K
-67.41%-902.11K
-37.71%-1.7M
-115.05%-26.74M
-3,624.47%-23.51M
63.93%-1.46M
81.28%-538.87K
Basic earnings per share
74.13%-200
89.20%-19
96.20%-5.7
50.00%-4
33.33%-2
-3,260.87%-773
63.03%-176
-254.64%-150
94.97%-8
97.52%-3
Diluted earnings per share
74.13%-200
89.20%-19
96.20%-5.7
50.00%-4
33.33%-2
-3,197.01%-773
63.03%-176
-682.63%-150
94.97%-8
97.52%-3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 54.09%7.54M454.42%24.09M94.94%7.68M4,385.93%5.96M3,599.67%5.56M3,890.42%4.89M1,802.41%4.35M4,528.68%3.94M163.63%132.81K184.27%150.31K
Operating revenue 54.09%7.54M454.42%24.09M94.94%7.68M4,385.93%5.96M3,599.67%5.56M3,890.42%4.89M1,802.41%4.35M4,528.68%3.94M163.63%132.81K184.27%150.31K
Cost of revenue 69.17%5.19M494.69%15.75M108.77%5.11M5,931.06%3.97M4,731.24%3.61M5,023.12%3.07M2,148.18%2.65M3,895.36%2.45M237.24%65.78K303.36%74.68K
Gross profit 28.78%2.35M391.53%8.34M72.22%2.57M2,869.42%1.99M2,482.18%1.95M2,811.02%1.83M1,434.03%1.7M6,157.61%1.49M117.12%67.03K120.10%75.62K
Operating expense 1.31%3.7M26.55%13.12M-42.47%3.76M55.17%2.77M281.42%2.94M184.34%3.66M306.57%10.37M2,051.20%6.53M238.63%1.79M82.39%771.42K
Selling and administrative expenses 7.63%3.36M14.26%10.83M-56.02%2.82M71.76%2.44M237.71%2.44M239.24%3.13M408.01%9.48M2,966.82%6.41M371.58%1.42M217.18%723.19K
-Selling and marketing expense 54.83%198.05K27.01%734.25K30.14%231.26K11.13%241.9K51.89%133.18K34.59%127.91K--578.09K--177.7K--217.67K--87.68K
-General and administrative expense 5.62%3.17M13.43%10.1M-58.48%2.59M82.72%2.2M263.35%2.31M262.78%3M377.03%8.9M2,881.83%6.23M299.38%1.2M178.73%635.51K
Research and development costs -48.71%222.03K128.59%1.86M1,854.67%816.33K-34.34%238.01K702.22%368.57K19.71%432.93K20.77%811.86K-54.21%41.76K62.95%362.5K-76.04%45.94K
Depreciation amortization depletion 22.78%42.62K492.72%149.15K123.16%42.35K4,616.10%37.21K1,425.01%34.88K1,016.08%34.71K97.50%25.16K496.01%18.98K-75.21%789-28.35%2.29K
-Depreciation and amortization 22.78%42.62K492.72%149.15K123.16%42.35K4,616.10%37.21K1,425.01%34.88K1,016.08%34.71K97.50%25.16K496.01%18.98K-75.21%789-28.35%2.29K
Other taxes 19.12%75.9K424.57%289.74K39.02%76.78K--52.59K--96.65K--63.72K--55.23K--55.23K--0--0
Operating profit 26.16%-1.35M44.83%-4.79M76.43%-1.19M54.63%-779.47K-42.23%-989.62K-49.50%-1.83M-255.47%-8.67M-1,701.26%-5.04M-246.19%-1.72M-79.05%-695.8K
Net non-operating interest income expense -45.08%94.91K40.78%674.67K85.04%157.5K-35.27%168.9K20.14%175.45K1,443.64%172.81K245.75%479.24K332.38%85.12K656.97%260.94K174.65%146.04K
Non-operating interest income -32.63%144.09K56.56%811.97K68.01%187.61K-20.51%207.43K39.03%203.05K7,129,266.67%213.88K--518.65K--111.67K--260.94K7,302,050.00%146.04K
Non-operating interest expense 19.73%49.18K248.39%137.31K13.43%30.11K1,926,250.00%38.53K--27.6K219.30%41.08K-88.01%39.41K-27.53%26.55K-100.00%2--0
Other net income (expense) -38,546.67%-5.77K100.00%-245100.00%-3960.00%40-102.40%-261266.67%15-89.46%-18.32M-1,963.70%-18.33M100.00%25100.47%10.88K
Gain on sale of security -38,546.67%-5.77K48.53%-24592.51%-3960.00%40-1,000.00%-261266.67%15-1,052.00%-476-2,842.11%-521-32.43%25262.50%29
Special income (charges) ------0--0--0--0-----89.46%-18.32M-1,963.69%-18.33M--0100.47%10.85K
-Less:Impairment of capital assets ------0------------------18.33M------------
-Less:Other special charges -------------------------100.11%-10.85K--0-----100.47%-10.85K
Income before tax 23.83%-1.26M84.49%-4.11M95.58%-1.03M58.10%-610.53K-51.14%-814.43K-33.97%-1.66M-113.17%-26.51M-3,589.50%-23.28M63.93%-1.46M81.28%-538.87K
Income tax -51.69%22.35K69.38%395.17K-5.59%220.27K40.95K87.68K46.27K233.3K233.3K00
Net income 24.59%-1.28M83.15%-4.51M94.68%-1.25M55.29%-651.48K-67.41%-902.11K-37.71%-1.7M-115.05%-26.74M-3,624.47%-23.51M63.93%-1.46M81.28%-538.87K
Net income continuous Operations 24.59%-1.28M83.15%-4.51M94.68%-1.25M55.29%-651.48K-67.41%-902.11K-37.71%-1.7M-115.05%-26.74M-3,624.47%-23.51M63.93%-1.46M81.28%-538.87K
Minority interest income
Net income attributable to the parent company 24.59%-1.28M83.15%-4.51M94.68%-1.25M55.29%-651.48K-67.41%-902.11K-37.71%-1.7M-115.05%-26.74M-3,624.47%-23.51M63.93%-1.46M81.28%-538.87K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 24.59%-1.28M83.15%-4.51M94.68%-1.25M55.29%-651.48K-67.41%-902.11K-37.71%-1.7M-115.05%-26.74M-3,624.47%-23.51M63.93%-1.46M81.28%-538.87K
Basic earnings per share 74.13%-20089.20%-1996.20%-5.750.00%-433.33%-2-3,260.87%-77363.03%-176-254.64%-15094.97%-897.52%-3
Diluted earnings per share 74.13%-20089.20%-1996.20%-5.750.00%-433.33%-2-3,197.01%-77363.03%-176-682.63%-15094.97%-897.52%-3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg